Global Brain Monitoring Market is expected to foresee significant growth during the forecast period. North America to witness the highest growth

Global Brain Monitoring market is expected to reach the market valuation of USD XX million by 2027 expanding at a reasonable CAGR of XX% during the forecast period (2021-2027) from USD XX million in 2020. Brain Monitoring is a branch of healthcare that deals with enhancing people’s athletic performance. Brain monitoring devices are used to monitor and diagnose neurological conditions by exploring the structure and function of the brain. This process involves the use of several brain monitoring devices such as electroencephalography devices, intracranial pressure monitors, and magnetoencephalography to track brain functions. In addition, these devices help monitor neural and electrical activity in the brain. At present, there is an increase in the demand for electroencephalography devices among healthcare providers.

The growth of this market is driven owing to increasing incidence and prevalence of neurological disorders, rising awareness of neurodegenerative diseases and growth in the number of traumatic brain injuries. For instance, according to WHO data, in September 2019, around 50 million people are affected by dementia globally, with nearly 10 million new cases registered each year. It is one of the major causes of disability and dependency among older people worldwide. Also, in June 2019, globally, the number of people affected with epilepsy was approximately 50 million; of this, nearly 80% live in low- and middle-income countries according to WHO data.

For a detailed analysis of the Brain Monitoring market browse through – https://univdatos.com/report/brain-monitoring-market/

Increasing prevalence of neurological disorders over many years, like Parkinson’s disease, Epilepsy, Alzheimer’s disease and others act as the major factors in driving the growth of the global brain monitoring market. This can primarily be attributed to the growing geriatric population. Having a seizure can result in injury due to falling, drowning, or car accidents, but perhaps the most common cause of death from epilepsy is from sudden unexpected death in epilepsy (SUDEP). SUDEP is still poorly understood, but is assumed to be associated with respiratory, cardiac, and cerebral factors. In 2019, there were 1,852 deaths in the U.S. with epilepsy as the underlying cause. Rates of death from epilepsy are higher for older people, with 1.6 deaths per 100,000 population among those aged 85 years and older, compared to an average rate of around 0.5 among those aged 15 to 24 years.

However, some of the restraints in the market are high cost of complex brain monitoring procedures and devices, stringent government regulations and unfavorable reimbursement policies. The high cost of brain monitoring surgeries and devices is a major factor restraining the global brain monitoring market, especially in developing countries with poor reimbursement policies. Brain monitoring devices are highly complex, and the procedures involving the use of these devices are generally expensive. For instance, the average cost of a standard EEG is around USD 200–700; this procedure can cost as high as USD 3,000 for extended monitoring. A dual-channel TCD costs approximately USD 3,000–3,200, and an ICP monitor costs approximately USD 340–500. Likewise, a single MEG system costs roughly USD 2.5–3 million. Due to the high price, healthcare facilities, even in countries that show wide adoption of high-tech medical equipment, find it difficult to procure MEG devices. Additionally, the maintenance cost and other associated indirect expenses increase the total cost of ownership of these devices, thereby limiting their adoption.

Request for Sample of the report browse through – https://univdatos.com/get-a-free-sample-form-php/?product_id=8941

Based on end user segment, the market is segmented into hospitals, neurology centers, diagnostic centers, ASCs & clinics, and other end users. The hospitals & clinics segment held the largest share in the Brain Monitoring Market in 2020. Brain monitoring is a complex process, requiring expensive and advanced devices and equipment that are mainly found in hospitals. Hospitals also see a considerably larger inflow of patients as compared to small clinics and other end users. Additionally, brain monitoring devices pose a considerable burden in terms of maintenance expenses on healthcare facilities; hospitals, more than other end-users, can bear such costs.

Also, preference for the diagnosis and treatment of brain disorders at neurology centers is increasing among patients, thereby expected to witness highest growing CAGR over the coming years.

Additionally, the report provides detailed initiatives that are being taken in the field of Brain Monitoring. The market is classified into distinct regions North America (United States, Canada, and the Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom and Rest of Europe), Asia-Pacific (China, Japan, India, South Korea, and Rest of APAC), Rest of World has been conducted. North America is expected to dominate the Brain Monitoring market owing to increasing incidence and prevalence of neurological disorders, growing number of clinical trials of brain monitoring products and the availability of medical reimbursement in the US.

Request for Sample of the report browse through – https://univdatos.com/get-a-free-sample-form-php/?product_id=8941

Approximately 30,000 people in America had Huntington’s disease, and more than 200,000 people were at risk in 2017 according to Huntington’s Disease Society of America. Additionally, the average incidence of epilepsy each year in the US is estimated at 150,000 or 48 for every 100,000 people (Source: Epilepsy Foundation). In the US, around 3.4 million people are affected by epilepsy.

The high adoption of technology and high penetration of mobile device have given this market an edge over other regions. The brain monitoring devices market in North America is also being encouraged by the supportive regulatory framework and affordable healthcare plans.

Natus Medical, Inc., Nihon Kohden Corporation, Philips Healthcare, GE Healthcare, Siemens Healthineers, Compumedics, Ltd., Medtronic, CAS Medical Systems, Drägerwerk AG & Co. KGaA and Masimo Corporation are some of the prominent players operating in the global brain monitoring market. Several M&A’s along with partnerships have been undertaken by these players to develop new and innovative products.

Global Brain Monitoring Market Segmentation

Market Insight, by Type

• Devices
  • Magnetic Resonance Imaging (MRI) Scanners
  • Computerized Tomography (CT) Scanners
  • Electroencephalograph (EEG) Devices
  • Positron Emission Tomography (PET) Scanners
  • Sleep Monitoring Devices
  • Cerebral Oximeters
  • Electromyography (EMG) Devices
  • Intracranial Pressure (ICP) Monitors
  • Magnetoencephalography (MEG) Devices
• Accessories

Market Insight, by Procedure

• Invasive
• Non-invasive

Market Insight, by Medical Condition

• Traumatic Brain Injury (TBI)
• Stroke
• Dementia
• Headache Disorders
• Sleep Disorders
• Parkinson’s Disease
• Epilepsy
• Huntington’s Disease
• Others

Market Insight, by End-User

• Hospitals
• Neurology Centers
• Ambulatory Surgery Centers (ASCs) & Clinics
• Diagnostic Centers
• Others

Market Insight, by Region

• North America
  • United States
  • Canada
  • Rest of North America
• Europe
  • France
  • Germany
  • Italy
  • Spain
  • United Kingdom
  • Rest of Europe
• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Rest of Asia-Pacific
• Rest of World

Top Company Profiles

• Natus Medical, Inc.
• Nihon Kohden Corporation
• Philips Healthcare
• GE Healthcare
• Siemens Healthineers
• Compumedics, Ltd.
• Medtronic
• CAS Medical Systems, Inc.
• Drägerwerk AG & Co. KGaA
• Masimo Corporation